Work

Urate Oxidase (Rasburicase) to Inhibit Graft Versus Host Disease (GVHD) After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation (HCT).

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.3063.3063

Authors: Andrew M. Brunner, Thomas R. Spitzer, Yi-Bin A. Chen, Erin Coughlin, Steven L. McAfee, Karen K. Ballen, Eyal C. Attar, Martin Caron, Frederic I. Preffer, Beow Y Yeap, Bimalangshu R Dey

Institutions: Harvard University, Massachusetts General Hospital

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556774397

FWCI: 0.192

Cites:

Cited by: 1

Related to: 10